Stay updated on Esketamine Safety in Treatment-Resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page.

Latest updates to the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page
- Check2 days agoChange DetectedA new revision entry v3.4.1 was added to the record history, replacing the previous v3.4.0 entry.SummaryDifference0.0%

- Check10 days agoChange DetectedRecord History now shows a glossary toggle, green highlights for additions, red highlights for deletions, and an updated revision label (v3.4.0).SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision v3.3.4 was added to the Record History, and revision v3.3.3 was removed.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page history adds a new site revision entry 'Revision: v3.3.3' and removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedThe government funding notice was removed, affecting only ancillary guidance; otherwise the study record history and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Esketamine Safety in Treatment-Resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page.